Heron Therapeutics, Inc. share price logo

Heron Therapeutics, Inc. Share Price

NASDAQ: HRTX

Small Cap

$1.10

(+0.45%)

as on

Heron Therapeutics, Inc. Stock Performance

as on November 8, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $1.05
    $1.12
    downward going graph

    4.55%

    Downside

    1.82%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.04
    $2.68
    downward going graph

    5.45%

    Downside

    143.64%

    Upside

    downward going graph

Heron Therapeutics, Inc. share price movements today

Previous Close
$1.10
Open
$1.11
Volume
2.6M
Day's Low - High
$1.05 - $1.12
52 Week Low - High
$1.04 - $2.68

Heron Therapeutics, Inc. Historical Returns

1 Month Return
-18.52 %
3 Month Return
-16.67 %
1 Year Return
-37.14 %
3 Year Return
-68.12 %
5 Year Return
-93.3 %

Heron Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Heron Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$201.7M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

-0.18

EBITDA

4.0M

Revenue (TTM)

155.1M

Profit Margin

-8.76%

Return On Equity TTM

-2408.88%

Heron Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Heron Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$201.7M-93.3%NA-8.76%
BUY$40.5B482.44%-16.34-264.83%
BUY$58.2B238.64%1420.941.36%
BUY$105.6B85.89%29.3331.35%
BUY$68.0B13.75%15.5132.13%

Stock Returns calculator for Heron Therapeutics, Inc. Stock including INR - Dollar returns

The Heron Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Heron Therapeutics, Inc. investment value today

Current value as on today

₹67,964

Returns

₹32,036

(-32.04%)

Returns from Heron Therapeutics, Inc. Stock

₹37,143 (-37.14%)

Dollar Returns*

₹5,107 (+5.11%)

Analyst Recommendation on Heron Therapeutics, Inc. Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Heron Therapeutics, Inc.. Average target price of $4.5

Heron Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Heron Therapeutics, Inc..

What analysts predicted

75.56%UPSIDE

Target Price

$4.5

Current Price

$1.1

Analyzed by

10 Analysts

Target

$4.50

Heron Therapeutics, Inc. target price $4.5, a slight upside of 75.56% compared to current price of $1.1. According to 10 analysts rating.

Heron Therapeutics, Inc. Stock’s Investor Sentiment and Interest

Search interest for Heron Therapeutics, Inc. Stock has increased by 92% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:92% versus previous 30 day period

Heron Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
31
31
34
34
36
32
40
38
37
38
Gross Profit
11
13
24
26
25
23
30
30
27
22
Operating Income
-42
-24
-10
-4
-6
-4
4
3
-1
-4
EBITDA
-41
-24
-5
-4
-5
-3
8
3
-1
-3
Interest Expense
0
0
2
0
0
0
4
0
0
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-42
-25
-10
-3
-9
-4
3
2
-2
-17
Income Tax Expense
0
0
0
0
-
-
-
-
-
-
Net Income
-42
-25
-10
-3
-9
-4
3
2
-2
-17
Net Profit Margin
-132.42%
-79.56%
-31.33%
-9.11%
-25.64%
-14.78%
8.98%
6.77%
-6.40%
-45.78%

Heron Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
1
30
77
145
88
86
107
127
144
Gross Profit
-61
1
26
49
84
52
40
52
61
105
Operating Income
-96
-170
-194
-183
-210
-228
-217
-174
-110
-11
EBITDA
-96
-169
-192
-182
-201
-225
-214
-171
-103
-5
Interest Expense
0
2
3
2
1
1
2
2
3
6
Depreciation
-
-
1
1
2
2
3
2
2
2
Income Before Tax
-97
-173
-197
-178
-204
-227
-220
-182
-110
-13
Income Tax Expense
0
-1
3
7
1
-2
-3
-47
2
-
Net Income
-97
-173
-197
-178
-204
-224
-217
-134
-110
-13
Net Profit Margin
0.00%
-13537.37%
-641.87%
-230.84%
-140.27%
-253.20%
-252.08%
-124.93%
-87.02%
-9.41%

Heron Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-25
-10
-3
-9
-4
3
2
-2
-17
Operating Cash Flow
-9
2
-9
-4
3
-11
-8
-10
1
Investing Cash Flow
-23
-8
1
2
3
11
2
7
11
Financing Cash Flow
53
0
0
0
0
0
0
0
13
Change in Cash
21
-6
-8
-2
7
0
-6
-2
26

Heron Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-173
-197
-178
-204
-227
-220
-182
-110
-13
Operating Cash Flow
-134
-170
-191
-124
-184
-203
-146
-58
-22
Investing Cash Flow
14
7
-278
-21
208
32
-3
17
18
Financing Cash Flow
57
293
357
186
9
156
75
54
0
Change in Cash
-61
131
-112
40
33
-14
-75
13
-2

Global Institutional Holdings in Heron Therapeutics, Inc.

Funds
Holdings
Rubric Capital Management LP
17.43%
BlackRock Inc
6.59%
Vanguard Group Inc
5.53%
Adage Capital Partners Gp LLC
5.12%
Velan Capital Investment Management LP
4.56%

Insights on Heron Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 37.2M → 38.21M (in $), with an average increase of 2.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 152.5% return, outperforming this stock by 189.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 897.2% return, outperforming this stock by 965.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 3.66M → -17.49M (in $), with an average decrease of 284.4% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, HRTX stock has moved down by -49.3%

About Heron Therapeutics, Inc.

heron therapeutics, inc. (formerly a.p. pharma, inc.) is a specialty pharmaceutical company developing products using its proprietary biochronomer™ polymer-based drug delivery platform. this drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
OrganisationHeron Therapeutics, Inc.
Headquarters100 Regency Forest Drive, Cary, NC, United States, 27518
IndustryHealth Technology
CEOMr. Craig Alexander Collard
E-voting on sharesClick here to vote

Key Management of Heron Therapeutics, Inc.

Name

Title

Mr. Brett Fleshman

Chief Business Officer

Dr. William P. Forbes Pharm. D., Pharm.D.

Executive VP & Chief Development Officer

Mr. Mark E. Hensley

Executive VP & COO

Melissa Jarel

Executive Director of Legal

Mr. Ryan Craig

Vice President of Marketing

Mr. John Aiken

Executive Director of People Management & Training

Dr. John C. Arthur Ph.D.

Senior Vice President of Manufacturing & Supply

Mr. Craig Alexander Collard

CEO & Director

Ms. Ira Duarte

Executive VP & CFO

Mr. Robert Sullivan

Senior Vice President of Oncology Care Franchise & Commercial Operations

FAQs

What is Heron Therapeutics, Inc. share price today?

Heron Therapeutics, Inc. share price today is $1.1 as on at the close of the market. Heron Therapeutics, Inc. share today touched a day high of $1.12 and a low of $1.05.

What is the 52 week high and 52 week low for Heron Therapeutics, Inc. share?

Heron Therapeutics, Inc. share touched a 52 week high of $2.68 on and a 52 week low of $1.04 on . Heron Therapeutics, Inc. stock price today i.e. is closed at $1.1,which is 58.96% down from its 52 week high and 5.77% up from its 52 week low.

What is Heron Therapeutics, Inc.'s market capitalisation today?

Heron Therapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Heron Therapeutics, Inc. Stock (HRTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Heron Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Heron Therapeutics, Inc. Shares that will get you 1.3636 shares as per Heron Therapeutics, Inc. share price of $1.1 per share as on November 8, 2025 at 2:29 am IST.

What is the minimum amount required to buy Heron Therapeutics, Inc. Stock (HRTX) from India?

Indian investors can start investing in Heron Therapeutics, Inc. (HRTX) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Heron Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Heron Therapeutics, Inc. share’s latest price of $1.1 as on November 8, 2025 at 2:29 am IST, you will get 9.0909 shares of Heron Therapeutics, Inc.. Learn more about fractional shares .

What are the returns that Heron Therapeutics, Inc. has given to Indian investors in the last 5 years?

Heron Therapeutics, Inc. stock has given -93.3% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?